XPOVIO® Now Funded in Saskatchewan

Sep 1, 2023

FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Saskatchewan as of September 1st. Please see the following link for full funding criteria: Drug Formulary (

We are excited about this important milestone for patients in Saskatchewan.

Read on LinkedIn